The global low molecular weight heparin pharmaceutical market continues to expand steadily, driven by growing demands for postoperative thrombosis prophylaxis, hemodialysis anticoagulation, and chronic vascular disease management. As a long-acting and high-safety LMWH raw material, Dalteparin Sodium API features stable anticoagulant activity and excellent biocompatibility, widely used in clinical treatment and generic drug formulation worldwide. For global pharmaceutical manufacturers and cross-border distributors, partnering with a professional and reliable Dalteparin Sodium API Company is critical to ensuring batch stability, regulatory compliance, and sustainable supply chain operation. Jiulong, a specialized biopharmaceutical enterprise with mature heparin deep-processing technology, has become a leading and trustworthy Dalteparin Sodium API Company for global high-standard pharmaceutical procurement.

　　What distinguishes Jiulong from ordinary factories as a professional Dalteparin Sodium API Company is our precise controlled nitrous acid depolymerization technology. The core quality advantage of qualified Dalteparin Sodium API lies in fixed average molecular weight range and stable anti-Xa/anti-IIa activity ratio, which directly determines finished drug efficacy and clinical safety. Most generic manufacturers adopt uncontrollable depolymerization processes, resulting in scattered molecular distribution, unstable activity and excessive impurity residues, bringing huge risks for drug registration and clinical application. As a dedicated Dalteparin Sodium API Company focusing on international pharmacopeia standards, Jiulong locks every reaction parameter through staged reaction control and multi-stage purification. This sophisticated craftsmanship ensures every batch of Dalteparin Sodium API maintains uniform molecular structure, high purity and stable potency, fully meeting USP and EP specifications.

　　As a compliance-oriented Dalteparin Sodium API Company with decades of export experience, Jiulong builds a full-process biological safety and traceability system. We strictly select high-quality traceable raw materials to eliminate source quality risks, and implement standardized production in GMP-certified automated workshops. The whole production process includes professional viral inactivation, microbial detection and residual impurity screening, ensuring full biological safety of Dalteparin Sodium API. Each finished batch is equipped with complete COA test reports, batch production records and technical dossiers. These comprehensive qualification documents fully support third-party factory audits, overseas drug registration and cross-border customs clearance, helping global clients quickly access European, American and Southeast Asian mainstream pharmaceutical markets.